Bio-based ether solvent and ionic liquid electrolyte for sustainable sodium-air batteries.

Sodium-air batteries (SABs) are receiving considerable attention for the development of next generation battery alternatives due to their high theoretical energy density (up to 1105 W h kg-1). However, most of the studies on this technology are still based on organic solvents; in particular, diglyme, which is highly flammable and toxic for the unborn child. To overcome these safety issues, this research investigates the first use of a branched ether solvent 1,2,3-trimethoxypropane (TMP) as an alternative electrolyte to diglyme for SABs. Through this work, the reactivity of the central tertiary carbon in TMP towards bare sodium metal was identified, while the addition of N-butyl-N-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide ([C4mpyr][TFSI]) as a co-solvent proved to be an effective strategy to limit the reactivity. Moreover, a Na-ß-alumina disk was employed for anode protection, to separate the TMP-based electrolyte from the sodium metal. The new cell design resulted in improved cell performance: discharge capacities of up to 1.92 and 2.31 mA h cm-2 were achieved for the 16.6 mol% NaTFSI in TMP and 16.6 mol% NaTFSI in TMP/[C4mpyr][TFSI] compositions, respectively. By means of SEM, Raman and 23Na NMR techniques, NaO2 cubes were identified to be the major discharge product for both electrolyte compositions. Moreover, the hybrid electrolyte was shown to hinder the formation of side-products during discharge - the ratio of NaO2 to side-products in the hybrid electrolyte was 2.4 compared with 0.8 for the TMP-based electrolyte - and a different charge mechanism for the dissolution of NaO2 cubes for each electrolyte was observed. The findings of this work demonstrate the high potential of TMP as a base solvent for SABs, and the importance of careful electrolyte composition design in order to step towards greener and less toxic batteries.

Sulindac Sulfide Induces the Formation of Large Oligomeric Aggregates of the Alzheimer's Disease Amyloid-ß Peptide Which Exhibit Reduced Neurotoxicity.

Alzheimer's disease is characterized by deposition of the amyloid ß-peptide (Aß) in brain tissue of affected individuals. In recent years, many potential lead structures have been suggested that can potentially be used for diagnosis and therapy. However, the mode of action of these compounds is so far not understood. Among these small molecules, the nonsteroidal anti-inflammatory drug (NSAID) sulindac sulfide received a lot of attention. In this manuscript, we characterize the interaction between the monomeric Aß peptide and the NSAID sulindac sulfide. We find that sulindac sulfide efficiently depletes the pool of toxic oligomers by enhancing the rate of fibril formation. In vitro, sulindac sulfide forms colloidal particles which catalyze the formation of fibrils. Aggregation is immediate, presumably by perturbing the supersaturated Aß solution. We find that sulindac sulfide induced Aß aggregates are structurally homogeneous. The C-terminal part of the peptide adopts a ß-sheet structure, whereas the N-terminus is disordered. The salt bridge between D23 and K28 is present, similar as in wild type fibril structures. (13)C-(19)F transferred echo double resonance experiments suggest that sulindac sulfide colocalizes with the Aß peptide in the aggregate.

Small-molecule conversion of toxic oligomers to nontoxic ß-sheet-rich amyloid fibrils.

Several lines of evidence indicate that prefibrillar assemblies of amyloid-ß (Aß) polypeptides, such as soluble oligomers or protofibrils, rather than mature, end-stage amyloid fibrils cause neuronal dysfunction and memory impairment in Alzheimer's disease. These findings suggest that reducing the prevalence of transient intermediates by small molecule-mediated stimulation of amyloid polymerization might decrease toxicity. Here we demonstrate the acceleration of Aß fibrillogenesis through the action of the orcein-related small molecule O4, which directly binds to hydrophobic amino acid residues in Aß peptides and stabilizes the self-assembly of seeding-competent, ß-sheet-rich protofibrils and fibrils. Notably, the O4-mediated acceleration of amyloid fibril formation efficiently decreases the concentration of small, toxic Aß oligomers in complex, heterogeneous aggregation reactions. In addition, O4 treatment suppresses inhibition of long-term potentiation by Aß oligomers in hippocampal brain slices. These results support the hypothesis that small, diffusible prefibrillar amyloid species rather than mature fibrillar aggregates are toxic for mammalian cells.